Clinical trials are better, faster, cheaper with big data

By Medidata

Nine out of 10 clinical trials worldwide can’t recruit enough people within their target timeframes. What if researchers didn’t need to recruit a control group at all and could offer the experimental treatment to everyone in the study? Download this white paper, in partnership with MIT Technology Review, to learn how Celsion, a biotechnology company developing next-generation chemotherapy and immunotherapy agents, leverages Medidata’s detailed information from 23,000+ trials and 7 million patients to create “external control arms” and speed up the clinical trial process.

Enter your details to receive the free white paper:

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.